Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001649094-24-000052
Filing Date
2024-08-06
Accepted
2024-08-06 16:09:33
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-20240630.htm   iXBRL 10-Q 1734432
2 EX-31.1 pcvx-20240630x10qxexx311.htm EX-31.1 10551
3 EX-31.2 pcvx-20240630x10qxexx312.htm EX-31.2 10562
4 EX-32.1 pcvx-20240630x10qxexx321.htm EX-32.1 7139
  Complete submission text file 0001649094-24-000052.txt   7906322

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20240630.xsd EX-101.SCH 65805
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcvx-20240630_cal.xml EX-101.CAL 78663
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcvx-20240630_def.xml EX-101.DEF 254334
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20240630_lab.xml EX-101.LAB 710688
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20240630_pre.xml EX-101.PRE 489502
85 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20240630_htm.xml XML 979699
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 241179279
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)